XML 82 R13.htm IDEA: XBRL DOCUMENT v3.19.3
Restructuring and impairment charges (credits)
 9 Months Ended
Sep. 29, 2019
Restructuring and Related Activities [Abstract]  
Restructuring and impairment charges (credits) Restructuring and impairment charges
The following tables provide information regarding restructuring and impairment charges recognized by the Company for the three and nine months ended September 29, 2019 and September 30, 2018: 
Three Months Ended September 29, 2019   
Termination benefits
Other costs (1)
Total
(Dollars in thousands) 
2019 Footprint realignment plan$584  $38  $622  
2018 Footprint realignment plan315  74  389  
Other restructuring programs (2)
7  250  257  
Restructuring charges$906  $362  $1,268  
Three Months Ended September 30, 2018   
Termination benefits
Other costs (1)
Total
(Dollars in thousands) 
2018 Footprint realignment plan$1,119  $145  $1,264  
Other restructuring programs (4)
468  232  700  
Restructuring charges1,587  377  1,964  
Asset impairment charges—  17,245  17,245  
Restructuring and impairment charges$1,587  $17,622  $19,209  
Nine Months Ended September 29, 2019  
Termination Benefits
Other costs (1)
Total
(Dollars in thousands)
2019 Footprint realignment plan$13,100  $68  $13,168  
2018 Footprint realignment plan(1,523) 782  (741) 
Other restructuring programs (2)
195  815  1,010  
Restructuring charges11,772  1,665  13,437  
Asset impairment charges—  6,911  6,911  
Restructuring and impairment charges$11,772  $8,576  $20,348  
Nine Months Ended September 30, 2018  
Termination Benefits
Other costs (1)
Total
(Dollars in thousands)
2018 Footprint realignment plan$53,463  $275  $53,738  
2016 Footprint realignment plan (3)
2,379  417  2,796  
Other restructuring programs (4)
1,318  663  1,981  
Restructuring charges57,160  1,355  58,515  
Asset impairment charges—  19,110  19,110  
Restructuring and impairment charges$57,160  $20,465  $77,625  
(1) Other restructuring costs include facility closure, contract termination and other exit costs.
(2) Includes a restructuring program initiated in the third quarter 2019 that is designed to reduce costs and improve efficiencies through reorganizations within several businesses and certain corporate functions, the Vascular Solutions integration program (initiated in 2017) and the 2016 and 2014 Footprint realignment plans.
(3) The 2016 Footprint realignment plan involved the relocation of certain manufacturing operations, the relocation and outsourcing of certain distribution operations and a related workforce reduction at certain of the Company's facilities. The program is substantially complete and the Company expects future restructuring expenses associated with the program, if any, to be immaterial.
(4) Includes the Vascular Solutions integration program, the 2014 Footprint realignment plan and the EMEA restructuring program (initiated in 2017).

2019 Footprint Realignment Plan
In February 2019, the Company initiated a restructuring plan primarily involving the relocation of certain manufacturing operations to existing lower-cost locations and related workforce reductions (the "2019 Footprint realignment plan"). These actions are expected to be substantially completed during 2022. The following table provides a summary of the Company’s estimates of restructuring and restructuring related charges by major type of expense associated with the 2019 Footprint realignment plan:
Type of expenseTotal estimated amount expected to be incurred
Termination benefits
$19 million to $23 million
Other exit costs (1)
$1 million to $2 million
Restructuring charges
$20 million to $25 million
Restructuring related charges (2)
$36 million to $45 million
Total restructuring and restructuring related charges
$56 million to $70 million
(1)Includes facility closure, employee relocation, equipment relocation and outplacement costs.
(2)Restructuring related charges represent costs that are directly related to the 2019 Footprint realignment plan and principally constitute costs to transfer manufacturing operations to existing lower-cost locations, project management costs and accelerated depreciation. Most of these charges are expected to be recognized within cost of goods sold.
In addition to the restructuring charges shown in the tables above, the Company recorded restructuring related charges with respect to the 2019 Footprint realignment plan of $1.9 million and $3.6 million, respectively, for the three and nine months ended September 29, 2019 within cost of goods sold.
As of September 29, 2019, the Company has a restructuring reserve of $11.8 million in connection with this plan, all of which relate to termination benefits.
2018 Footprint Realignment Plan
On May 1, 2018, the Company initiated a restructuring plan involving the relocation of certain European manufacturing operations to existing lower-cost locations, the outsourcing of certain of the Company’s European distribution operations and related workforce reductions (the “2018 Footprint realignment plan"). These actions are expected to be substantially completed by the end of 2024.
The Company recorded restructuring related charges with respect to the 2018 Footprint realignment plan of $0.8 million and $2.1 million for the three and nine months ended September 29, 2019, respectively, and $1.8 million and $2.8 million for the three and nine months ended September 30, 2018, respectively. The restructuring related charges were included within cost of goods sold. The majority of the restructuring related charges in both periods constituted costs arising from the transfer of manufacturing operations to new locations.
The Company estimates that it will incur aggregate pre-tax restructuring and restructuring related charges in connection with the 2018 Footprint realignment plan of approximately $102 million to $133 million, respectively. As of September 29, 2019, the Company has incurred aggregate restructuring charges in connection with the 2018 Footprint realignment plan of $54.3 million, principally related to termination benefits. In addition, as of September 29, 2019, the Company has incurred aggregate restructuring related charges of $6.2 million with respect to the 2018 Footprint realignment plan, consisting of accelerated depreciation and certain other costs that principally resulted from the transfer of manufacturing operations to new locations. The restructuring related charges primarily were included in cost of goods sold. As of September 29, 2019, the Company has a restructuring reserve of $44.0 million in connection with this plan, all of which related to termination benefits.
2014 Footprint Realignment Plan
In 2014, the Company initiated a restructuring plan (“the 2014 Footprint realignment plan”) involving the consolidation of operations and a related reduction in workforce at certain facilities, and the relocation of manufacturing operations from certain higher-cost locations to existing lower-cost locations. These actions commenced in the second quarter 2014 and are expected to be substantially completed during 2021.

The Company recorded restructuring related charges with respect to the 2014 Footprint realignment plan of $0.8 million and $2.1 million for the three and nine months ended September 29, 2019, respectively, and $0.8 million and $1.8 million for the three and nine months ended September 30, 2018, respectively. The majority of these restructuring related charges in both periods constituted costs arising from the transfer of manufacturing operations to new locations.
The Company estimates that it will incur aggregate pre-tax restructuring and restructuring related charges in connection with the 2014 Footprint realignment plan of $47 million to $52 million, respectively. As of September 29, 2019, the Company has incurred aggregate restructuring charges of $12.8 million in connection with the 2014
Footprint realignment plan, principally related to termination benefits. Additionally, as of September 29, 2019, the Company has incurred aggregate restructuring related charges of $31.2 million in connection with the 2014 Footprint realignment plan, consisting of accelerated depreciation and certain other costs that principally resulted from the transfer of manufacturing operations from the existing locations to new locations. These restructuring related charges primarily were included in cost of goods sold. As of September 29, 2019, the Company has a restructuring reserve of $3.7 million in connection with the plan, all of which related to termination benefits. As the restructuring programs progress, management will reevaluate the estimated expenses and charges set forth above, and may revise its estimates, as appropriate, consistent with GAAP. For additional information related to the restructuring programs, see Note 5 to the Company's consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2018.